[Pulmonary alveolar microlithiasis: Report of one case]

Revista Medica De Chile
|November 27, 2014
PubMed

Insights

Pulmonary alveolar microlithiasis is a rare lung disease causing calcified particle buildup. This case highlights a 39-year-old female with progressive dyspnea, showcasing the disease's characteristic "sandstorm" pattern.

Area of Science:

  • Pulmonology
  • Rare Diseases
  • Genetics

Background:

  • Pulmonary alveolar microlithiasis (PAM) is an ultra-rare interstitial lung disease.
  • Characterized by diffuse intra-alveolar accumulation of calcified microliths.
  • Caused by mutations in the SLC34A2 gene, affecting alveolar surface transport.

Observation:

  • A 39-year-old female presented with worsening shortness of breath.
  • Imaging revealed ground-glass opacities on chest X-ray.
  • High-resolution CT scan demonstrated numerous calcified lung micronodules, consistent with the "sandstorm" pattern.

Findings:

  • Surgical lung biopsy confirmed the diagnosis of pulmonary alveolar microlithiasis.
  • Microliths are microscopic, calcified, spherical deposits within the lung alveoli.
  • The disease progression is typically slow, leading to pulmonary fibrosis and respiratory failure.

Implications:

  • Early diagnosis is crucial for managing progressive lung disease.
  • Understanding the genetic basis may lead to targeted therapies.
  • This case underscores the importance of characteristic imaging findings in diagnosing rare lung conditions.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
22